Enhanced Silkworm Cecropin B Antimicrobial Activity against Pseudomonas aeruginosa from Single Amino Acid Variation

Ottavia Romoli1, Shruti Mukherjee2, Sk Abdul Mohid2

  • 1Department of Biology , University of Padova , Via Ugo Bassi 58/B , 35131 Padova , Italy.

Insights

Two cecropin B isoforms from silkworms show potent antimicrobial activity against Pseudomonas aeruginosa. The Q53 CecB variant exhibits superior efficacy due to enhanced membrane interaction, offering a promising new therapeutic candidate.

Area of Science:

  • Microbiology
  • Biochemistry
  • Biophysics

Background:

  • Pseudomonas aeruginosa infections pose a significant threat, especially in vulnerable populations like cystic fibrosis patients.
  • Increasing antimicrobial resistance in P. aeruginosa necessitates the discovery of novel therapeutic agents.
  • Antimicrobial peptides (AMPs) represent a promising class of compounds for combating resistant bacterial strains.

Purpose of the Study:

  • To investigate the antimicrobial activity and mechanisms of two cecropin B (CecB) isoforms from Bombyx mori against Pseudomonas aeruginosa.
  • To compare the efficacy of the E53 CecB and Q53 CecB isoforms, which differ by a single amino acid substitution.
  • To elucidate the molecular interactions underlying the antimicrobial action of these CecB variants.

Main Methods:

  • Antimicrobial susceptibility testing and membrane-disruption assays were performed.
  • Biophysical analyses, including live-cell Nuclear Magnetic Resonance (NMR), were utilized.
  • Molecular dynamics simulations were employed to study peptide-membrane interactions.

Main Results:

  • Both E53 CecB and Q53 CecB demonstrated significant antimicrobial and membranolytic activity against P. aeruginosa.
  • The Q53 CecB isoform exhibited greater antimicrobial potency than the E53 CecB isoform.
  • Studies indicated that both peptides disrupt the bacterial outer membrane, facilitating translocation to the inner membrane, with Q53 CecB showing enhanced membrane interaction and stability.

Conclusions:

  • The single amino acid variation in Q53 CecB is crucial for its enhanced antimicrobial activity against P. aeruginosa.
  • Q53 CecB displays favorable properties, including stability and low human cell toxicity, making it a promising lead for developing new anti-P. aeruginosa therapeutics.
  • Cecropin B isoforms represent a viable strategy for developing novel antimicrobial compounds against challenging bacterial pathogens.

Related Concept Videos

Amino acids03:42

Amino acids

Amino acids are the monomers that comprise proteins. Each amino acid has the same fundamental structure, which consists of a central carbon atom, or the alpha (α) carbon, bonded to an amino group (NH2), a carboxyl group (COOH), and to a hydrogen atom. Every amino acid also has another atom or group of atoms bonded to the central atom known as the R group. There are 20 common amino acids present in proteins, each with a different R group. Variation in the amino acid sequence is responsible for...
104.8K
Amino Acid Catabolism01:18

Amino Acid Catabolism

Microorganisms rely on proteins as an essential carbon and energy source, particularly in environments with limited polysaccharides or lipids. However, proteins are too large to cross the plasma membrane unaided, necessitating enzymatic degradation. Microbes secrete extracellular proteases and peptidases that hydrolyze proteins into peptides, which can then be transported across the membrane. Once inside the cell, intracellular proteases degrade these peptides into free amino acids, which...
1.1K
Amino Acid Biosynthetic Pathways01:29

Amino Acid Biosynthetic Pathways

Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which...
1.2K
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids01:19

Phase II Reactions: Sulfation and Conjugation with α-Amino Acids

Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...
923
What is Variation?01:14

What is Variation?

Apart from the measures of central tendency, distribution, outliers, and the changing characteristics of data with time, an important characteristic of any data set is its variation or spread. In some data sets, the data values are concentrated closely near the mean; in others, the data values are more widely spread out from the mean.
The range, standard deviation, standard error, and variance are the different measures of variation.
Range: The range is the difference between its maximum and...
17.6K
tRNA Activation02:26

tRNA Activation

Aminoacyl-tRNA synthetases are present in both eukaryotes and bacteria. Though eukaryotes have 20 different aminoacyl-tRNA synthetases to couple to 20 amino acids, many bacteria do not have genes for all of these aminoacyl-tRNA synthetases. Despite this, they still use all 20 amino acids to synthesize their proteins. For instance, some bacteria do not have the gene encoding the enzyme that couples glutamine with its partner tRNA. In these organisms, one enzyme adds glutamic acid to all of the...
22.7K